Scientific Articles

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

 

Elena Elez, M.D., Ph.D., Takayuki Yoshino, M.D., Ph.D., Lin Shen, M.D., Sara Lonardi, M.D., Eric Van Cutsem, M.D., Ph.D., Cathy Eng, M.D., Tae Won Kim, M.D., Ph.D., Harpreet Singh Wasan, M.D., Jayesh Desai, F.R.A.C.P. https://orcid.org/0000-0003-4246-9344, Fortunato Ciardiello, M.D., Ph.D., Rona Yaeger, M.D., Timothy S. Maughan, M.D., Van K. Morris, M.D., Christina Wu, M.D., Tiziana Usari, B.Sc., Robert Laliberte, M.S., Samuel S. Dychter, M.D., Xiaosong Zhang, M.D., Ph.D., Josep Tabernero, M.D., Ph.D., and Scott Kopetz, M.D., Ph.D., for the BREAKWATER Trial Investigators

The New England Journal of Medicine,  May 30 2025

Abstract link

Privacy Overview
AIOM

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.